Summary
Vasoactive intestinal polypeptide (VIP) is released into the portal circulation in large quantities by ischaemic bowel. In view of its known high concentration in the gut and potent vasoactive properties it may well be implicated in the pathogenesis of the serious haemodynamic changes produced by gut ischaemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. M. Makhlouf and S. I. Said, Symposium of Gastrointestinal Hormones. Austin University of Texas Press 1975.
M. Bryant, S. Bloom, I. Modlin, J. Polak and A. Pearse and H. Alburquerque, Lancet1, 991 (1976).
A. M. Ebeid, P. Murray, P. Soeters and J. Fisher, Am. J. Surg.133, 140 (1977).
O. B. Schaffalitzky de Muckadell, J. Fahrenkrug and J. J. Holst, Gastroenterology2, 3373 (1977).
I. M. Modlin, S. R. Bloom and S. Mitchell. Gut18, 418 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Modlin, I.M., Bloom, S.R. & Mitchell, S. Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia. Experientia 34, 535–536 (1978). https://doi.org/10.1007/BF01935976
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01935976